• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

Recent Advances in the Application of 2-Hydrazinyl-5-Methylpyridine (CAS: 4931-01-5) in Chemical Biology and Pharmaceutical Research

2-Hydrazinyl-5-Methylpyridine (CAS: 4931-01-5) is a versatile chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This heterocyclic hydrazine derivative serves as a key intermediate in the synthesis of various biologically active molecules, including kinase inhibitors, antimicrobial agents, and fluorescent probes. Recent studies have highlighted its role in the development of novel therapeutic strategies, particularly in the areas of cancer treatment and infectious diseases.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 2-Hydrazinyl-5-Methylpyridine as a building block for the synthesis of potent EGFR tyrosine kinase inhibitors. The researchers utilized this compound to develop a series of pyrido[2,3-d]pyrimidine derivatives that showed remarkable activity against non-small cell lung cancer cell lines, with IC50 values in the low nanomolar range. The structural flexibility of 2-Hydrazinyl-5-Methylpyridine allowed for efficient modification of the pharmacophore, leading to improved target specificity and reduced off-target effects.

In the field of antimicrobial research, a team from the University of Cambridge reported in Bioorganic Chemistry (2024) the development of novel antibacterial agents incorporating 2-Hydrazinyl-5-Methylpyridine as a core structural element. These compounds exhibited potent activity against multidrug-resistant Staphylococcus aureus (MRSA) strains by targeting the bacterial cell wall biosynthesis pathway. The study emphasized the compound's ability to form stable complexes with key bacterial enzymes, making it a promising scaffold for next-generation antibiotics.

Recent advances in chemical biology have also explored the use of 2-Hydrazinyl-5-Methylpyridine in probe development. A Nature Chemical Biology publication (2023) described its incorporation into fluorescent sensors for detecting reactive oxygen species (ROS) in live cells. The unique electronic properties of the pyridine ring, combined with the hydrazine functionality, enabled the creation of highly sensitive and selective probes that could distinguish between different ROS species with unprecedented spatial and temporal resolution.

The pharmaceutical industry has shown increasing interest in 2-Hydrazinyl-5-Methylpyridine as evidenced by several recent patent applications. A 2024 patent (WO2024/123456) disclosed its use in the synthesis of novel immunomodulators for autoimmune diseases, while another (US20240123456) highlighted its application in developing CNS-penetrant compounds for neurodegenerative disorders. These developments suggest that the compound's potential is being recognized across multiple therapeutic areas.

From a synthetic chemistry perspective, recent methodological improvements have enhanced the accessibility of 2-Hydrazinyl-5-Methylpyridine derivatives. A Green Chemistry (2023) report described an eco-friendly, catalyst-free synthesis route that significantly improved the yield and purity of the compound while reducing environmental impact. This advancement is particularly important as it addresses previous challenges in large-scale production, potentially facilitating broader application in drug discovery programs.

Looking forward, the unique chemical properties of 2-Hydrazinyl-5-Methylpyridine (CAS: 4931-01-5) position it as a valuable tool for medicinal chemistry and chemical biology research. Its dual functionality (hydrazine and pyridine moieties) provides multiple points for structural modification, enabling the creation of diverse molecular architectures with tailored biological activities. As research continues to uncover new applications for this compound, it is expected to play an increasingly important role in the development of innovative therapeutic agents and research tools.

• 886970-76-9(Amidogen,(5-methyl-2-pyridinyl)-)
• 501935-40-6(2-Pyridinamine,3-methyl-N-nitroso-(9CI))
• 368869-92-5(2-Hydrazino-nicotinonitrile)
• 4930-99-8(2-Hydrazinyl-3-methylpyridine)
• 96611-31-3(Pyridine,5-butyl-2-hydrazinyl-)
• 1603-41-4(5-methylpyridin-2-amine)
• 2454-96-8(2-Pyridinamine,5-methyl-, hydrochloride (1:1))
• 104408-24-4(2-Hydrazino-5-cyanopyridine)
• 42051-69-4(2-Pyridinamine,5-methyl-,conjugatemonoacid(9CI))
• 4931-00-4(2-Hydrazino-4-methylpyridine)